Bayer has announced it will discontinue the sale of the Company’s controversial permanent birth control device for women – Essure – in Canada. This follows similar actions taken by the Company in the UK and Finland, and an outright ban of Essure by the National Health Surveillance Agency (ANVISA) in Brazil. According to a recent article, Essure remains the subject of a potential class-action lawsuit in Canada involving hundreds of women. Many of these individuals have undergone hysterectomies due to complications related to Essure.
If you or a loved one suffered complications after receiving an Essure implant, please contact us at (888) 985-7228 for a confidential evaluation of your potential claim.